Ensartinib
Drug timelines are a Plus or Pro feature.
17 regulatory and trial events tracked for Ensartinib, covering 2018-08-21 to 2026-04-13. Get the full timeline:
Most recent: Clinical Trial Update: Ensartinib in Treating Patients With Relapsed or Refractory Advanced Solid Tumors, Non-Hodgkin Lymphoma, or Histiocytic Disorders With ALK or ROS1 Genomic Alterations (A Pediatric MATCH Treatment Trial) [Phase 2]